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CORRESPONDENCE
Tackling climate change: measuring the carbon footprint of 
preventing, diagnosing and treating TB
A. D. Harries,1,2 L. Martinez,3 J. M. Chakaya1,4,5
Dear Editor,The last three issues of Public Health Action in 
2020 have included seven papers on TB preventive 
therapy. This illustrates not only the growing interest 
in the topic but also the critical role of this strategy in 
ending TB. The United Nations High-Level Meeting 
on TB in September 2018 specifically mentioned the 
need to provide preventive therapy to at least 30 mil-
lion people between 2018 and 2022.1 From the per-
spective of individual disease and community trans-
mission of infection, prevention is always better than 
cure. The prevention argument is further strengthened 
by mounting evidence of the considerable burden of 
post-TB morbidity and disability-adjusted life-years 
that occurs after successful completion of treatment 
and which can be averted by preventing TB from de-
veloping in the first place.2 However, despite the com-
pelling arguments for preventive therapy, progress has 
been slow. Between 2018 and 2019, only 6.3 million 
people globally received treatment for TB infection.3
We need further drivers to persuade us that preven-
tion of TB is a sound strategy. One such driver may be 
Sustainable Development Goal 13, which demands ur-
gent action to combat climate change and its impact. 
The Intergovernmental Panel on Climate Change (Ge-
neva, Switzerland) has made it clear that limiting global 
heating to 1.5°C above pre-industrial levels should re-
duce the serious public health catastrophes of bush fires 
and floods that the world is starting to experience.4 To 
achieve this, carbon dioxide emissions (known as “car-
bon footprints”), need to halve by 2030 and to reach 
net zero by 2050.4 Emissions of other greenhouse gases 
must also reach net zero between 2050 and 2070.
Health care professionals can play an important 
part here. Health care is substantially more energy-in-
tensive than many other commercial and service ac-
tivities, and is estimated to contribute between 4% 
and 6% of global emissions.5 Indeed, in some high-in-
come settings, health care activities can reach as high 
as 10% of total emissions.6 While the carbon foot-
prints of some medical and surgical procedures and 
treatments have been estimated (for example, renal 
dialysis, cataract surgery, laparoscopic surgery and 
asthma inhalers),5 the vast majority have not been 
quantified, including the diagnosis, treatment and 
prevention of TB.
We exhort health care scientists experienced in 
measuring and estimating carbon dioxide emissions to 
investigate in low-, middle- and high-income coun-
tries the carbon footprint of diagnosing and treating 
drug-susceptible and drug-resistant TB, of providing 
care for post-TB morbidity and disability and of pre-
venting TB from ever occurring in the first place. It is 
likely that TB disease prevention will have a much 
lower carbon footprint than the laborious process of 
diagnosis and treatment of the disease by cutting the 
demand for TB care. If this is shown to be so, this 
would provide a further incentive to health policy 
makers and national TB programmes to include pre-
ventive therapy for at-risk groups, as cost-effectiveness 
may be beneficial from a societal perspective. Poten-
tially, the argument for preventing TB becomes much 
more powerful, with the tool becoming one of many 
we can use to help save the planet.
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